All Stories

  1. Left ventricular hypertrophy reporting, analysis and trial design
  2. The Placebo Effect in Chronic Thromboembolic Pulmonary Hypertension Trials: A Systematic Review and Meta-Analysis
  3. Association of Aspirin Use in Primary Prevention and Cardiovascular Events: A Retrospective Analysis of the VITAL Cohort
  4. Risk of infective endocarditis in patients with mitral valve prolapse: Systematic review with meta-analysis
  5. In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 2018
  6. Role of myocardial microRNAs in the long-term ventricular remodelling of patients with aortic stenosis
  7. A Reconciliação da Medicação nos Cuidados de Saúde em Portugal
  8. The SAFEST study: The crucial role of primary health care in the diagnosis and management of atrial fibrillation
  9. Editor's Choice – Systematic Review and Meta-Analysis of Contemporary Abdominal Aortic Aneurysm Growth Rates
  10. Incidence of muscle symptoms in placebo arm among statin-intolerant patients: a systematic review with meta-analysis
  11. Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemic
  12. How to predict prognosis in patients with acute pulmonary embolism? Recent advances
  13. Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF
  14. Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis
  15. Direct oral anticoagulants vs vitamin K antagonist on dementia risk in atrial fibrillation: systematic review with meta-analysis
  16. Anticoagulação Oral e Incidência de Acidente Vascular Cerebral Associado a Fibrilhação Auricular em Portugal Continental: Um Estudo de Modelação
  17. Clinical Outcomes of Anticoagulated Patients With Atrial Fibrillation After Falls or Head Injury: Insights From RE-LY
  18. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis
  19. Expert perspectives on strategic factors for the management and prevention of heart failure in Portugal
  20. Endometriosis and cardiovascular disease: A systematic review and meta-analysis
  21. Prescrição de Benzodiazepinas e outros Sedativos na Administração Regional de Saúde de Lisboa e Vale do Tejo de 2013 a 2020: Um Estudo Retrospetivo
  22. Glossopharyngeal neuralgia with cardioinhibitory syncope: Is a permanent pacemaker required?
  23. Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis
  24. Myocardial infarction and viral triggers: what do we know by now?
  25. Aspirin in diabetic patients at primary prevention: insights of the VITAL cohort
  26. Family history of premature myocardial infarction and the effect of aspirin
  27. Fish intake and risk of cardiovascular events: an analysis of the VITAL cohort
  28. Screening strategies for atrial fibrillation in the elderly population: a systematic review and network meta-analysis
  29. Cardiovascular and Respiratory Safety of Sedation Strategies Used in Transesophageal Echocardiography: A Systematic Review Incorporating Network Meta-Analysis
  30. Management of arterial hypertension: Challenges and opportunities
  31. The Accuracy of Hestia and Simplified PESI to Predict the Prognosis in Pulmonary Embolism: Systematic Review with Meta-analysis
  32. Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis
  33. Systematic Review and Meta-analysis of Physician Modified Endografts for Treatment of Thoraco-Abdominal and Complex Abdominal Aortic Aneurysms
  34. The sham effect of invasive interventions in chronic coronary syndromes: a systematic review and meta-analysis
  35. The association of xanthelasma palpebrum with cardiovascular events: systematic review with meta-analysis
  36. Systematic reviews and meta-analysis published in indexed Portuguese medical journals: time trends and critical appraisal
  37. High sensitivity troponins: From the acute setting to the general population
  38. Does autosomal dominant polycystic kidney disease increase the risk of aortic aneurysm or dissection: a point of view based on a systematic review and meta-analysis
  39. Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis
  40. Incidence of acute aortic dissections in patients with out of hospital cardiac arrest: A systematic review and meta-analysis of observational studies
  41. Anticoagulation therapy in patients with post-operative atrial fibrillation: Systematic review with meta-analysis
  42. A systematic review and meta-analysis of the incidence of acute aortic dissections in population-based studies
  43. Incidence and Prevalence of Thoracic Aortic Aneurysms: A Systematic Review and Meta-analysis of Population-Based Studies
  44. The high-risk bleeding category of different scores in patients with venous thromboembolism: Systematic review and meta-analysis
  45. Abstract 11500: General Evaluation of the Aorta by Computed Tomography in a Latin Population
  46. COVID-19 and myocardial infarction
  47. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
  48. Risk of SARS‐CoV‐2 Infection and COVID‐19 Severity Associated With Exposure to Nonsteroidal Anti‐Inflammatory Drugs: Systematic Review and Meta‐Analysis
  49. Anticoagulation after typical atrial flutter ablation: Systematic review and meta‐analysis
  50. Low-Dose Colchicine in Coronary Artery Disease ― Systematic Review and Meta-Analysis ―
  51. Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis
  52. The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews
  53. The Impact of Different Types of Shift Work on Blood Pressure and Hypertension: A Systematic Review and Meta-Analysis
  54. Cardiovascular and cerebrovascular risk markers in Parkinson’s disease: Results from a case−control study
  55. Atherosclerosis: The cost of illness in Portugal
  56. Os custos da aterosclerose em Portugal
  57. Does Parkinson's Disease Increase the Risk of Atrial Fibrillation? Insights From Electrocardiogram and Risk Scores From a Case-Control Study
  58. Cochrane Corner: Withdrawal of antihypertensive drugs in older people
  59. Cochrane Corner: Withdrawal of antihypertensive drugs in older people
  60. Doxycycline is not Effective in Reducing Abdominal Aortic Aneurysm Growth: A Mini Systematic Review and Meta-Analysis of Randomised Controlled Trials
  61. Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them?
  62. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe
  63. Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 infection severity
  64. Soluble CD40 ligand expression in stable atherosclerosis: A systematic review and meta-analysis
  65. The Risk of Mortality Associated With Opioid Use in Patients With Acute Heart Failure: Systematic Review and Meta-analysis
  66. Safety and tolerability of sacubitril-valsartan: a systematic review and meta-analysis
  67. Fluoroquinolones Are Associated With Increased Risk of Aortic Aneurysm or Dissection: Systematic Review and Meta-analysis
  68. The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention
  69. Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysis
  70. The incidence of thrombotic events with idarucizumab and andexanet alfa: A systematic review and meta-analysis
  71. Opioids prescribing trend between 2013 and 2017 in the Lisbon and Tagus Valley region, Portugal
  72. Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis
  73. Synchronous and Metachronous Thoracic Aortic Aneurysms in Patients With Abdominal Aortic Aneurysms: A Systematic Review and Meta‐Analysis
  74. Reminder: Cardiovascular Patients Also Benefit from Influenza Vaccine
  75. Safety of coffee consumption after myocardial infarction: A systematic review and meta-analysis
  76. Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment
  77. Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis
  78. Effect of oxygen supply on mortality in acute ST-elevation myocardial infarction: systematic review and meta-analysis
  79. N‐Terminal Pro‐B‐Type Natriuretic Peptide Levels in Parkinson's Disease
  80. Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials
  81. The burden of atherosclerosis in Portugal
  82. Multimodality imaging in the recurrence of left ventricular pseudoaneurysm after surgical correction
  83. The impact of SSRIs on mortality and cardiovascular events in patients with coronary artery disease and depression: systematic review and meta-analysis
  84. Alterações Eletrocardiográficas Induzidas pela Hipotermia
  85. Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis
  86. Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis
  87. Reply to the letter ‘We never speak about sudden unexpected death in Parkinson’s disease’
  88. Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis
  89. Cardiovascular Adverse Events Reported in Placebo Arm of Randomized Controlled Trials in Parkinson’s Disease
  90. Cardiovascular events reported in randomized controlled trials in restless legs syndrome
  91. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review
  92. Reporting and methodological quality of clinical trials on exercise therapy for Parkinson's disease
  93. Reply to letter: Does Parkinson’s disease increase the risk of cardiovascular events? A systematic review and meta‐analysis
  94. Physical Activity, Exercise, and Physiotherapy in Parkinson's Disease: Defining the Concepts
  95. The association of Influenza infection and vaccine with myocardial infarction: systematic review and meta-analysis of self-controlled case series.
  96. Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: Contemporaneous Portuguese cross-sectional data
  97. Recommendations and levels of evidence in the guidelines of the European Society of Cardiology: current scenario and time trends
  98. Cochrane Corner: Perioperative beta-blockers for preventing surgery-related mortality and morbidity
  99. Does Parkinson's disease increase the risk of cardiovascular events? A systematic review and meta‐analysis
  100. Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies
  101. Corrigendum to “Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis” [Arch. Gerontol. Geriatr. 81 (March–April) (2019) 209–214]
  102. Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
  103. Morphine in acute coronary syndrome: systematic review and meta-analysis
  104. Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: A systematic review with meta-analysis and trial sequential analysis
  105. Ibrutinib increases the risk of hypertension and atrial fibrillation: Systematic review and meta-analysis
  106. The current and future burden of heart failure in Portugal
  107. Fatores de Risco para Mortalidade Hospitalar na Endocardite Infecciosa
  108. Non-vitamin K antagonist oral anticoagulants (NOACs) in cardioversions: The past, the present and the future
  109. Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol
  110. Non-vitamin K antagonist oral anticoagulants and infective endocarditis
  111. Factors influencing patient delay before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The Stent for life initiative in Portugal
  112. Thrombus aspiration in patients with ST-elevation myocardial infarction: results of a national registry of interventional cardiology
  113. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
  114. Novel Antithrombotic Drugs and Intraocular Bleeding
  115. Influenza vaccination and prevention of cardiovascular disease mortality
  116. Adoção da estratégia invasiva precoce no enfarte agudo do miocárdio sem supra desnivelamento de ST: análise dos resultados do Registo Nacional de Síndromas Coronárias Agudas
  117. The value of Time in Therapeutic Range in the prediction of outcomes at a populational level in patients treated with vitamin K antagonists
  118. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
  119. Caffeine does not increase the arrhythmic burden in patients with heart failure and left ventricular systolic dysfunction
  120. Cardiac Harms of Sofosbuvir: Systematic Review and Meta-Analysis
  121. A era dos novos anticoagulantes orais em Portugal
  122. Accuracy of diagnostic tests for Legionnaires' disease: a systematic review
  123. Bioengineered Temporomandibular Joint Disk Implants: Study Protocol for a Two-Phase Exploratory Randomized Preclinical Pilot Trial in 18 Black Merino Sheep (TEMPOJIMS)
  124. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis
  125. Are there effective interventions to prevent hospital-acquired Legionnaires' disease or to reduce environmental reservoirs of Legionella in hospitals? A systematic review
  126. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis
  127. Safety of non-vitamin K antagonist oral anticoagulants - coronary risks
  128. Cochrane Corner: uso do balão intra‐aórtico em doentes com enfarte agudo do miocárdio complicado com choque cardiogénico
  129. Bridging Anticoagulation in Patients with Atrial Fibrillation
  130. Complicações de enfarte do miocárdio: ecocardiograma para diagnóstico diferencial de sopro cardíaco
  131. Custo‐efetividade dos novos anticoagulantes orais na fibrilhação auricular em Portugal
  132. Is the time in therapeutic range using the ratio of tests equivalent to the Rosendaal method?
  133. Cochrane Corner: colchicina na pericardite aguda e recorrente
  134. Glaucoma Surgery and Anticoagulant Therapy—Reply
  135. Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants
  136. Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants
  137. Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis
  138. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis
  139. Risk of renal failure with the non-vitamin K antagonist oral anticoagulants: systematic review and meta-analysis
  140. Left ventricular thrombus in repaired Tetralogy of Fallot
  141. Pericardial bleeding risk with non-vitamin K oral anticoagulants: A meta-analysis
  142. Takotsubo cardiomyopathy, beyond ventriculography and classical bidimensional echocardiography
  143. Non-vitamin K antagonist oral anticoagulants in the cardioversion of patients with atrial fibrillation: systematic review and meta-analysis
  144. Risk of insomnia with non-vitamin K oral anticoagulants: systematic review and meta-analysis
  145. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis
  146. Carga e custo da fibrilhação auricular em Portugal
  147. Cochrane Corner – administração de corticosteroides para miocardite de etiologia viral
  148. Antithrombotic treatment in chronic heart failure and sinus rhythm: Systematic review
  149. The burnout stage of an apical hypertrophic cardiomyopathy
  150. Thromboembolic risk in the initiation, switch and interruption/re-initiation of oral anticoagulants: Do newcomers improve outcomes? Insights from a meta-analysis of RCTs
  151. Cochrane Corner: Qual é o impacto clínico da administração de oxigénio em doentes com enfarte agudo do miocárdio? Avaliação de uma revisão sistemática Cochrane
  152. Controlled pericardiocentesis in patients with cardiac tamponade complicating aortic dissection: Experience of a centre without cardiothoracic surgery
  153. Prevalência da anticoagulação oral em doentes com fibrilhação auricular em Portugal: revisão sistemática e meta‐análise de estudos observacionais
  154. Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis
  155. Oral Anticoagulation for Pulmonary Arterial Hypertension: Systematic Review and Meta-analysis
  156. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis
  157. Impacto da frequência posológica na adesão terapêutica em doenças cardiovasculares crónicas: revisão sistemática e meta‐análise
  158. Net clinical benefit outcome should be standardized in trials evaluating antithrombotic drugs: The example of NOACs in atrial fibrillation
  159. Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta‐analysis
  160. Dyspnea and Reversibility Profile of P2Y12 Antagonists: Systematic Review of New Antiplatelet Drugs
  161. The risk of infection with new oral anticoagulants: A meta-analysis
  162. Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis
  163. Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study
  164. Cochrane corner - Antiagregantes plaquetários na doença renal crónica. Avaliação da revisão sistemática
  165. Warfarin, acetylsalicylic acid and risk of incident atrial fibrillation in patients with heart failure and sinus rhythm: A meta-analysis
  166. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies
  167. Infliximab Reduces Hospitalizations and Surgery Interventions in Patients With Inflammatory Bowel Disease
  168. Clinical applications of exercise stress echocardiography in the treadmill with upright evaluation during and after exercise
  169. Um caso de tromboembolismo pulmonar e dissecção aórtica: importância do ecocardiograma
  170. Branded Versus Generic Clopidogrel in Cardiovascular Diseases
  171. Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
  172. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
  173. Rate versus rhythm control in atrial fibrillation and clinical outcomes: Updated systematic review and meta-analysis of randomized controlled trials
  174. Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials
  175. Educational Strategies to Reduce Serum Phosphorus in Hyperphosphatemic Patients With Chronic Kidney Disease: Systematic Review With Meta-analysis
  176. Skin antiseptics in venous puncture-site disinfection for prevention of blood culture contamination: systematic review with meta-analysis
  177. Deep Purple Urine